Newly opened centre to advance safety in SA healthcare

A new collaboration, located within the University of Cape Town’s (UCT) Clinical Skills Centre, will help foster safer practices in healthcare through an educational focus on patient and healthcare worker safety.


NRF Health has added a convenient tube of buffered Vitamin C fizzy tablets with bioflavonoids, to their popular and affordable range of Vitamin C supplements.  Each handy pack contains 10 effervescent Vitamin C tablets which easily dissolve in a glass of water.

How non-communicable diseases (NCDs) can cause blindness.

In recent years, non-communicable diseases (NCDs) have risen in prominence on the global public health agenda. NCDs are not passed from person to person but are typically the result of a combination of genetic, physiological, environmental and behavioural factors, and they tend to progress slowly. The most common NCDs include cardiovascular diseases (such as heart attacks and stroke), cancers, chronic respiratory diseases, and diabetes.


Vaginal dryness is common after menopause. The symptoms can include painful intercourse, itching or burning, vaginal discomfort, and frequent urination. It’s not easy to talk about, but it’s totally normal, and more common than you think.

Dynaval – New Product Launch

Pharma Dynamics, South Africa’s leading supplier of cardiovascular medicines*, announces the addition of Dynaval (valsartan) to its extensive range of cardiovascular medicines.

Ground-breaking recycling project turns used medical consumables into much-needed school shoes for disadvantaged children.

 In a pioneering and collaborative move for the healthcare industry, a recycling project between Adcock Ingram Critical Care, Netcare, Executive Mayor, Councillor Herman Mashaba, and the City of Johannesburg, is helping hospitals deal with their safe healthcare waste in a way that creates functional new products, including school shoes for disadvantaged children.

Trends: High hopes for SA pharmaceutical progress in 2018

The world is currently benefiting from a wave of pharmaceutical breakthroughs including targeted ‘personalised’ treatment and biologics. In South Africa, which has traditionally lagged behind the rest of the world, requiring five to seven years in the licensing of new drugs compared to 18 months to two years in most western countries, there is cause for optimism on progress in 2018.